Literature DB >> 18257355

[Study on relation of ovary-body surface correlativity with acupoints].

Shao-Jun Wang1, Bing Zhu.   

Abstract

OBJECTIVE: To study the specific regularity of acupoints to treat genital system diseases.
METHODS: A model of inflammatory ovary was developed by injection of 0.08 mL, 10% mustard oil into the ovary of the rat. And the reactive points of plasma extravasarion points on the skin were detected after injection of 0.25 mL evens blue into the tail vein. The relation among the regions of plasma extravasation points, dorsal ganglion of governing ovaries and the acupoints to treat the ovarian diseases was analyzed.
RESULTS: The exudative points mainly distributed at Guanyuan (CV 4)-"Zigong" (EX-CA 1) point-area, "Shenshu" (BL 23)-"Mingmen" (GV 4) point-area, "Changqiang" (GV 1)-"Huiyin" (CV 1) point-area, "Sanyinjiao" (SF 6)-"Zusanli" (ST 36) point-area, "Zhongwan" (CV 12) point-area, "Gansho" (BL 18) area, with the most in the "Guanyuan" (CV 4)-"Zigong" (EX-CA 1) point-area and next at "Shenshu" (BL 23)-"Mingmen" (GV 4) point-area.
CONCLUSION: The reactive point-area of plasma extravasation resulted from inflammation of ovary are identical to the ovary a corr.sponding dorsal ganglion. Acupuncture at the corresponding acupoints of the reactive point-areas has specific regulative action on ovarian functions.

Entities:  

Mesh:

Year:  2007        PMID: 18257355

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

1.  Changes in responses of neurons in spinal and medullary subnucleus reticularis dorsalis to acupoint stimulation in rats with visceral hyperalgesia.

Authors:  Ling-Ling Yu; Liang Li; Pei-Jing Rong; Bing Zhu; Qing-Guang Qin; Hui Ben; Guo-Fu Huang
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-26       Impact factor: 2.629

2.  Visceral nociceptive afferent facilitates reaction of subnucleus reticularis dorsalis to acupoint stimulation in rats.

Authors:  Liang Li; Lingling Yu; Peijing Rong; Hui Ben; Xia Li; Bing Zhu; Rixin Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-15       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.